Vaxcyte Inc

PCVXNASDAQ · USD
60.37USD0.00 (+2.73%)
2210

Vaxcyte Inc (PCVX) Option Chain

As of September 16, 2026, Vaxcyte Inc is trading at $60.37, a +2.73% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 93.7%. IV Rank is 89%.

Read more

Tracking the PCVX option chain helps you see every strike and expiry on Vaxcyte Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Vaxcyte Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PCVX options activity at a glance. Use our scanner to monitor the PCVX option chain in real time and filter for the PCVX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PCVX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PCVX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PCVX stock options are being actively traded and where they are not.

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis.

The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Vaxcyte Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen PCVX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PCVX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile94.44% Elevated
  • Market cap (M$)8,983
  • 52 weeks high-7.12%
  • 52 weeks low95.44%
  • Analyst recommendationStrong Buy
    1.20
  • Target price$109.00
    80.55% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-03
  • P/E
  • Future P/E
  • EPS (ttm)-7.71
  • EPS growth next 5 years-2.37%

As of September 16, 2026

2026-09-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.7400-1.4710.376.8011.0050.00-14.924.800.004.800199.26
16.293010-1.295.372.156.0055.00-6.410.150.300.000.23031283.71
63.5460-0.020.370.100.6060.00+2.091.002.350.001.68071836.46
94.163610.250.000.2565.00+10.604.007.904.631.32005.84
99.654900.250.000.2570.00+19.119.0013.309.631.52000.35

As of September 16, 2026

Scan the full option chain in one place

Browse the full PCVX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial